{"favorite_id": 3111, "calc_type": "", "dosing": false, "full_title_en": "Revised Original Score for Autoimmune Hepatitis (AIH)", "short_title_en": "Revised Original AIH Score", "medium_description_en": "Revised version of the original scoring system for the diagnosis of autoimmune hepatitis.", "short_description_en": "Revised version of the original scoring system for autoimmune hepatitis.", "before_use": "", "instructions_en": "", "purpose_en": ["Diagnosis", "Rule Out"], "disease_en": ["Autoimmune Disorders", "Hepatitis"], "specialty_en": ["Allergy and Immunology", "Family Practice", "Gastroenterology", "Hepatology", "Internal Medicine"], "chief_complaint_en": ["Abdominal Pain", "Jaundice"], "system_en": ["Gastrointestinal", "Immunologic"], "search_abbreviation_en": ["AIH", "autoimmune hepatitis", "diagnosis", "revised aih"], "slug": "revised-original-score-autoimmune-hepatitis-aih", "seo": {"meta_description_en": "The Revised Original Score for Autoimmune Hepatitis (AIH) is the revised version of the original scoring system for diagnosis of autoimmune hepatitis.", "keywords_en": "revised AIH, revised original AIH, revised score AIH, Revised Original Score for AIH, revised original AIH score, revised AIH calc, revised AIH scoring, AIH score, AIH original score, new AIH score, changed AIH score, AIH calc, AIH, scale, pretreatment AIH score, post treatment AIH score, pre tx aih score, post tx aih score, autoimmune hepatitis"}, "content": {"how_to_use": {"use_case_en": "<p>Patients with established hepatitis and available liver biopsy results, but unclear diagnosis.</p>", "pearls_pitfalls_en": "", "why_use_en": "<p>AIH is multifactorial, complex, and typically has many competing diagnoses. The score offers a data driven, consensus-based path to help guide treatment.</p>"}, "next_steps": {"advice_en": "<p>AIH is a complex diagnosis partly because there is no anatomic criterion (i.e. \u2019gold\u2019) standard. The revised (1999), conventional AIH score solves this problem by defining the diagnosis, though some would say the recently developed, more specific, <calculator id='3112'>simplified version</calculator> offers a preferred alternative.</p>", "management_en": "<p>We are unaware of validated management algorithms using the AIH score.</p>", "critical_actions_en": "<p>Overlap with multiple conditions is always a concern to consider, despite score findings, and \u2018definite\u2019 scores are considerably more predictive than \u2018probable\u2019 scores.</p>"}, "about": {"formula_en": "<p dir=\"ltr\">Addition of the selected points:</p>\n<div dir=\"ltr\">\n<div dir=\"ltr\">\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p dir=\"ltr\"><strong>Variable</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p dir=\"ltr\">Sex</p>\n</td>\n<td>\n<p dir=\"ltr\">Male</p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Female</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\"><abbr title=\"Alkaline phosphatase\">ALP</abbr>:<abbr title=\"Aspartate aminotransferase\">AST</abbr> or <abbr title=\"Alkaline phosphatase\">ALP</abbr>:<abbr title=\"Alanine aminotransferase\">ALT</abbr> ratio</p>\n</td>\n<td>\n<p dir=\"ltr\">&lt;1.5</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1.5-3.0</p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;3.0</p>\n</td>\n<td>\n<p dir=\"ltr\">-2</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"4\">\n<p dir=\"ltr\">Serum globulins or IgG, times above upper limit of normal</p>\n</td>\n<td>\n<p dir=\"ltr\">&gt;2.0</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1.5-2.0</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1.0-1.5</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&lt;1.0</p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"4\">\n<p dir=\"ltr\">Antinuclear antibody (ANA), smooth muscle antibody (SMA), or liver/kidney microsomal type 1 (LKM-1) antibody</p>\n</td>\n<td>\n<p dir=\"ltr\">&gt;1:80</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1:80</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">1:40</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&lt;1:40</p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p dir=\"ltr\">Anti-mitochondrial antibody (AMA)</p>\n</td>\n<td>\n<p dir=\"ltr\">Positive</p>\n</td>\n<td>\n<p dir=\"ltr\">-4</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Negative</p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p dir=\"ltr\">Hepatitis viral markers<sup>1</sup></p>\n</td>\n<td>\n<p dir=\"ltr\">Positive</p>\n</td>\n<td>\n<p dir=\"ltr\">-3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Negative</p>\n</td>\n<td>\n<p dir=\"ltr\">+3</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p dir=\"ltr\">Recent or current use of hepatotoxic drugs</p>\n</td>\n<td>\n<p dir=\"ltr\">Yes</p>\n</td>\n<td>\n<p dir=\"ltr\">-4</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">No</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p dir=\"ltr\">Average alcohol intake</p>\n</td>\n<td>\n<p dir=\"ltr\">&lt;25&nbsp;g/day</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">25-60 g/day</p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;60 g/day</p>\n</td>\n<td>\n<p dir=\"ltr\">-2</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"6\">\n<p dir=\"ltr\">Liver histology</p>\n</td>\n<td>\n<p dir=\"ltr\">Interface hepatitis</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Predominantly lymphoplasmacytic infiltrate</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Rosetting of liver cells</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">No interface hepatitis, not predominantly lymphoplasmacytic infiltrate, and no rosetting of liver cells</p>\n</td>\n<td>\n<p dir=\"ltr\">-5</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Biliary changes (bile duct changes typical of primary biliary cirrhosis or primary scleroisng cholangitis, and/or periportal ductal reaction with copper-associated protein accumulation)</p>\n</td>\n<td>\n<p dir=\"ltr\">-3</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Other changes (any other prominent features suggesting different etiology)</p>\n</td>\n<td>\n<p dir=\"ltr\">-3</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p dir=\"ltr\">Other autoimmune disease(s) (in patient or 1st degree relatives)<sup>2</sup></p>\n</td>\n<td>\n<p dir=\"ltr\">No</p>\n</td>\n<td>\n<p dir=\"ltr\">0</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Yes</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p dir=\"ltr\">Optional additional parameters<sup>3</sup></p>\n</td>\n<td>\n<p dir=\"ltr\">Seropositivity for other defined autoantibodies<sup>4</sup></p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">HLA-DR3 or HLA-DR4</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p dir=\"ltr\">Response to therapy</p>\n</td>\n<td>\n<p dir=\"ltr\">Complete</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">Relapse</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n</div>\n<div dir=\"ltr\">\n<p dir=\"ltr\"><strong>Footnotes:</strong></p>\n<p dir=\"ltr\"><sup>1</sup> Hepatitis A, B and C viruses (i.e., positive/negative for IgM anti-HAV, HBsAg, IgM anti-HBc, anti-HCV and HCV-RNA); if all are negative and viral etiology is still suspected, CMV/EBV testing may be relevant.</p>\n<p dir=\"ltr\"><sup>2</sup>&nbsp;In patient or 1st degree relatives.</p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-1c9cadcb-7fff-ba89-49ee-acfd7de86863\"><sup>3</sup>&nbsp;</span>Assign points only in patients seronegative for ANA, SMA and LKM-1.<span></span></p>\n<p dir=\"ltr\"><span><sup>4</sup>&nbsp;</span>e.g. pANCA, anti-LCl, anti-SLA, anti-ASGPR, anti-LP and anti-sulfatide.&nbsp;</p>\n<p dir=\"ltr\"></p>\n</div>", "more_info_en": "<p dir=\"ltr\">Interpretation:</p>\n<p><span id=\"docs-internal-guid-7e20de3c-7fff-f337-a107-d3d1c92fdb56\"></span></p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"92\" /><col width=\"171\" /><col width=\"186\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>AIH Score </strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Pre- or post treatment</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Diagnosis</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;15</p>\n</td>\n<td rowspan=\"2\">\n<p dir=\"ltr\">Pre-treatment</p>\n</td>\n<td>\n<p dir=\"ltr\">Definite AIH</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">10-15</p>\n</td>\n<td>\n<p dir=\"ltr\">Probable AIH</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;17</p>\n</td>\n<td rowspan=\"2\">\n<p dir=\"ltr\">Post-treatment</p>\n</td>\n<td>\n<p dir=\"ltr\">Definite AIH</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">12-17</p>\n</td>\n<td>\n<p dir=\"ltr\">Probable AIH</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>", "evidence_based_medicine_en": "<p>The conventional AIH score has been tested by numerous groups, typically in referral populations using database and chart review validations. With many complex inputs the score codifies an accepted and user friendly approach to diagnosis, but has been criticized for low specificity and thus false positives, particularly in the \u2018probable AIH\u2019 category.</p>", "references_list": {"Original/Primary Reference": [{"href": "http://www.journal-of-hepatology.eu/article/S0168-8278(99)80297-9/fulltext", "text": "Alvarez, F. et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. Journal of Hepatology, Volume 31 , Issue 5 , 929 - 938."}], "Other References": [{"href": "", "text": ""}], "Validation": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/18924244", "text": " Czaja AJ. Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepat. 2008;48:1540-1548. "}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. Fernando Alvarez", "creator_info": {"about_en": "<p>Fernando Alvarez, MD, is the Chief of the Division of Gastroenterology, Hepatology &amp; Nutrition at CHU Sainte-Justine, University of Montreal. He studied medicine in his home country of Argentina, where he focused on hepatology and pediatrics. He currently practices pediatric hepatology, and he researches topics including autoimmune hepatitis, viral hepatitis, and liver immunity.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-fernando-alvarez.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Alvarez%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=10580593"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "toggle", "label_en": "Sex", "name": "sex", "options": [{"label": "Male", "value": 0}, {"label": "Female", "value": 2}], "conditionality": "", "show_points": true, "optional": false}, {"type": "radio", "label_en": "<abbr title='Alkaline phosphatase'>ALP</abbr>:<abbr title='Aspartate aminotransferase'>AST</abbr> or <abbr title='Alkaline phosphatase'>ALP</abbr>:<abbr title='Alanine aminotransferase'>ALT</abbr> ratio", "name": "ratio", "options": [{"label": "<1.5", "value": 2}, {"label": "1.5-3.0", "value": 0}, {"label": ">3.0", "value": -2}], "conditionality": "", "show_points": true, "default": 1, "optional": false}, {"type": "radio", "label_en": "Serum globulins or IgG", "name": "serum", "options": [{"label": ">2.0", "value": 3}, {"label": "1.5-2.0", "value": 2}, {"label": "1.0-1.5", "value": 1}, {"label": "<1.0", "value": 0}], "conditionality": "", "show_points": true, "default": 3, "tips_en": "Times above upper limit of normal", "optional": false}, {"type": "radio", "label_en": "<abbr title='Antinuclear antibody'>ANA</abbr>, <abbr title='Smooth muscle antibody'>SMA</abbr>, or <abbr title='Liver/kidney microsomal type 1'>LKM-1</abbr> antibody", "name": "ana", "options": [{"label": ">1:80", "value": 3}, {"label": "1:80", "value": 2}, {"label": "1:40", "value": 1}, {"label": "<1:40", "value": 0}], "conditionality": "", "show_points": true, "default": 3, "optional": false}, {"type": "radio", "label_en": "Optional additional parameters", "name": "addtl", "options": [{"label": "Seropositivity for other defined autoantibodies", "value": 2}, {"label": "HLA-DR3 or HLA-DR4", "value": 1}, {"label": "None of the above", "value": 0}], "conditionality": "ana == 0", "show_points": true, "tips_en": "If ANA, SMA, LKM-1 are negative", "optional": true}, {"type": "toggle", "label_en": "<abbr title='Anti-mitochondrial antibody'>AMA</abbr>", "name": "ama", "options": [{"label": "Positive", "value": -4}, {"label": "Negative", "value": 0}], "conditionality": "", "show_points": true, "default": 1, "optional": false}, {"type": "radio", "label_en": "Hepatitis viral markers", "name": "hepa", "options": [{"label": "Positive", "value": -3}, {"label": "Negative", "value": 3}], "conditionality": "", "show_points": true, "tips_en": " Hepatitis A, B and C viruses (i.e., positive/negative for IgM anti-HAV, HBsAg, IgM anti-HBc, anti-HCV and HCV-RNA); if all are negative and viral etiology is still suspected, CMV/EBV testing may be relevant", "optional": false}, {"type": "radio", "label_en": "Recent or current use of hepatotoxic drugs", "name": "drug", "options": [{"label": "Yes", "value": -4}, {"label": "No", "value": 1}], "conditionality": "", "show_points": true, "optional": false}, {"type": "radio", "label_en": "Average alcohol intake", "name": "alcohol", "options": [{"label": "<25 g/day", "value": 2}, {"label": "25-60 g/day", "value": 0}, {"label": ">60 g/day", "value": -2}], "conditionality": "", "show_points": true, "optional": false}, {"type": "toggle", "label_en": "Liver histology: interface hepatitis", "name": "liver_int", "options": [{"label": "Yes", "value": 3}, {"label": "No", "value": 0}], "conditionality": "", "show_points": true, "default": 1, "optional": false}, {"type": "toggle", "label_en": "Liver histology: predominantly lymphoplasmacytic infiltrate", "name": "liver_lymph", "options": [{"label": "Yes", "value": 1}, {"label": "No", "value": 0}], "conditionality": "", "show_points": true, "default": 1, "optional": false}, {"type": "toggle", "label_en": "Liver histology: rosetting of liver cells", "name": "liver_ros", "options": [{"label": "Yes", "value": 1}, {"label": "No", "value": 0}], "conditionality": "", "show_points": true, "default": 1, "tips_en": "If no interface hepatitis, not predominantly lymphoplasmacytic infiltrate, and no rosetting of liver cells, then subtract 5 points", "optional": false}, {"type": "toggle", "label_en": "Liver histology: biliary changes", "name": "liver_bil", "options": [{"label": "Yes", "value": -3}, {"label": "No", "value": 0}], "conditionality": "", "show_points": true, "default": 1, "tips_en": "Bile duct changes typical of primary biliary cirrhosis or primary scleroisng cholangitis, and/or periportal ductal reaction with copper-associated protein accumulation", "optional": false}, {"type": "toggle", "label_en": "Liver histology: other changes", "name": "liver_other", "options": [{"label": "Yes", "value": -3}, {"label": "No", "value": 0}], "conditionality": "", "show_points": true, "default": 1, "tips_en": "Any other prominent features suggesting different etiology", "optional": false}, {"type": "toggle", "label_en": "Other autoimmune disease(s) ", "name": "other", "options": [{"label": "Yes", "value": 2}, {"label": "No", "value": 0}], "conditionality": "", "show_points": true, "default": 1, "tips_en": "In patient or 1st degree relatives", "optional": false}, {"type": "radio", "label_en": "Response to therapy", "name": "resp", "options": [{"label": "Complete", "value": 2}, {"label": "Relapse", "value": 3}], "conditionality": "", "show_points": true, "optional": true}], "md5": "b9b13180fb966a4e306b3ff504cc7127", "related_calcs": [{"calcId": 3112, "short_title_en": "Simplified AIH Score", "slug": "simplified-autoimmune-hepatitis-aih-score"}, {"calcId": 2200, "short_title_en": "FIB-4 Index", "slug": "fibrosis-4-fib-4-index-liver-fibrosis"}, {"calcId": 3081, "short_title_en": "NAFLD Fibrosis Score", "slug": "nafld-non-alcoholic-fatty-liver-disease-fibrosis-score"}]}